RU2001134982A - METHOD OF IMMUNE RESPONSE CORRECTION AND MEDICINE - Google Patents

METHOD OF IMMUNE RESPONSE CORRECTION AND MEDICINE

Info

Publication number
RU2001134982A
RU2001134982A RU2001134982/15A RU2001134982A RU2001134982A RU 2001134982 A RU2001134982 A RU 2001134982A RU 2001134982/15 A RU2001134982/15 A RU 2001134982/15A RU 2001134982 A RU2001134982 A RU 2001134982A RU 2001134982 A RU2001134982 A RU 2001134982A
Authority
RU
Russia
Prior art keywords
activated
medicine
immune response
response correction
immune
Prior art date
Application number
RU2001134982/15A
Other languages
Russian (ru)
Inventor
Олег Ильич Эпштейн
Original Assignee
Олег Ильич Эпштейн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Олег Ильич Эпштейн filed Critical Олег Ильич Эпштейн
Priority to RU2001134982/15A priority Critical patent/RU2001134982A/en
Priority to AU2002313946A priority patent/AU2002313946A1/en
Priority to PCT/RU2002/000384 priority patent/WO2003055518A1/en
Publication of RU2001134982A publication Critical patent/RU2001134982A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Claims (3)

1. Способ лечения иммунопатологических состояний, при котором в организм вводят активированные сверхмалые дозы моноклональных или поликлональных, иммунных или естественных антител к CD4 молекуле Т лимфоцитов, при этом активированную (потенцированную) форму получают путем многократного последовательного разведения и внешнего воздействия.1. A method of treating immunopathological conditions in which activated ultra-low doses of monoclonal or polyclonal, immune or natural antibodies to the CD4 T lymphocyte molecule are administered, and the activated (potentiated) form is obtained by repeated serial dilution and external exposure. 2. Лекарственное средство, содержащее сверхмалые дозы моноклональных или поликлональных, иммунных или естественных антител в активированной форме к CD4 молекуле Т лимфоцитов, при этом активированную (потенцированную) форму получают путем многократного последовательного разведения и внешнего воздействия, преимущественно по гомеопатической технологии.2. A drug containing ultra-low doses of monoclonal or polyclonal, immune or natural antibodies in the activated form against the CD4 T lymphocyte molecule, while the activated (potentiated) form is obtained by repeated serial dilution and external exposure, mainly by homeopathic technology. 3. Лекарственное средство по п.2, отличающееся тем, что используют смеси различных, преимущественно сотенных, гомеопатических разведении.3. The drug according to claim 2, characterized in that use a mixture of various, mainly hundred, homeopathic dilutions.
RU2001134982/15A 2001-12-26 2001-12-26 METHOD OF IMMUNE RESPONSE CORRECTION AND MEDICINE RU2001134982A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
RU2001134982/15A RU2001134982A (en) 2001-12-26 2001-12-26 METHOD OF IMMUNE RESPONSE CORRECTION AND MEDICINE
AU2002313946A AU2002313946A1 (en) 2001-12-26 2002-08-13 Method for curing immunopathosis and medicinal agent for carrying out said method
PCT/RU2002/000384 WO2003055518A1 (en) 2001-12-26 2002-08-13 Method for curing immunopathosis and medicinal agent for carrying out said method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2001134982/15A RU2001134982A (en) 2001-12-26 2001-12-26 METHOD OF IMMUNE RESPONSE CORRECTION AND MEDICINE

Publications (1)

Publication Number Publication Date
RU2001134982A true RU2001134982A (en) 2004-02-20

Family

ID=20254870

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001134982/15A RU2001134982A (en) 2001-12-26 2001-12-26 METHOD OF IMMUNE RESPONSE CORRECTION AND MEDICINE

Country Status (3)

Country Link
AU (1) AU2002313946A1 (en)
RU (1) RU2001134982A (en)
WO (1) WO2003055518A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (en) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Method of treatment of pathological syndrome and medicinal agent
UA76639C2 (en) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Homeopathic medication and method for treating erectile dysfunctions
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
MY165267A (en) * 2010-07-15 2018-03-15 Oleg Lliich Epshtein Combination pharmaceutical composition and methods of treating genitourinary system disorders
PE20130397A1 (en) 2010-07-15 2013-04-10 Oleg Iliich Epshtein COMBINED PHARMACEUTICAL COMPOSITION AND METHODS FOR THE TREATMENT OF DISEASES OR FUNCTIONAL CONDITIONS OF THE GASTROINTESTINAL TRACT
RU2010133049A (en) * 2010-08-06 2012-02-20 Олег Ильич Эпштейн (RU) MEDICINAL PRODUCT AND METHOD FOR PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS
RU2535034C2 (en) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Medication and method of preventing hiv infection, prevention and treatment of hiv-induced or hiv-associated diseases, including aids
BR112013002296A2 (en) * 2010-08-06 2018-01-30 Lliich Epshtein Oleg pharmaceutical composition and its use and method for treating infectious disease
RU2517084C2 (en) * 2010-08-06 2014-05-27 Олег Ильич Эпштейн Method and means for inhibiting production or enhancing protein p24 elimination
RU2535033C2 (en) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Therapeutic agent and method for prevention of hiv infection and treatment of hiv-caused or hiv-associated diseases, including aids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
RU2187334C2 (en) * 1998-05-22 2002-08-20 Эпштейн Олег Ильич Method of correction of impaired immune homeostasis and medicinal agent
RU2156621C1 (en) * 1999-03-04 2000-09-27 Эпштейн Олег Ильич Neurotropic drug
RU2161034C1 (en) * 2000-08-02 2000-12-27 Новицкий Юрий Алексеевич Immunocorrecting proteoselenium agent and method of immunocorrection

Also Published As

Publication number Publication date
AU2002313946A1 (en) 2003-07-15
WO2003055518A1 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
RU2000115594A (en) METHOD FOR TREATMENT OF PATHOLOGICAL SYNDROME AND MEDICINE
RU2001134982A (en) METHOD OF IMMUNE RESPONSE CORRECTION AND MEDICINE
EA200101064A1 (en) TREATMENT OF CANCER DISEASES THROUGH COMBINED INTRODUCTION OF A DOCETIXEL WITH RECOMBINANT HUMANIZED MONOCLONAL ANTI-HER2 ANTI-TITLES
EA200200392A1 (en) THE METHOD OF OBTAINING EXTRACT FROM PLANTS OF TRICHOCAULON OR HODIA GENERA;
HUP0105490A2 (en) Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
US20060165697A1 (en) Medicinal agent and method for curing erectile dysfunction
RU98109384A (en) METHOD FOR CORRECTION OF DISTURBED IMMUNE HOMEOSTASIS AND MEDICINE
RU2187334C2 (en) Method of correction of impaired immune homeostasis and medicinal agent
DE69227500D1 (en) Monoclonal antibodies useful in the therapy of HIV-1 infection
Monroe et al. Anti-idiotypic antibodies and disease
RU2006119655A (en) Medicament for the oral treatment of diabetes and other diseases associated with impaired glucose tolerance, and methods for producing a solid dosage form for oral therapy of diabetes and other diseases associated with impaired glucose tolerance
ATE534666T1 (en) ANTIBODIES AGAINST HEPATITIS C VIRUS E1E2 COMPLEX AND PHARMACEUTICAL COMPOSITIONS
RU93048161A (en) COMBINED PEDIATRIC VACCINE WITH STRENGTHENED IMMUNOGENITY OF EACH VACCINARY COMPONENT
ATE122100T1 (en) HUMAN MONOCLONAL ANTIBODIES AND MEDICINAL COMPOSITION CONTAINING SAME FOR THE TREATMENT OF PSEUDOMONASIC INFECTIONS.
RU2002106708A (en) The drug and method for the treatment of pathological syndrome caused by impaired hematopoiesis
EA200300535A1 (en) METHOD FOR OBTAINING ANTIGENAL STRUCTURES STRENGTHENING SPECIFIC CROSS-REACTIVITY
RU2205026C1 (en) Medicinal agent and method of treatment of pathological syndrome caused by hemopoiesis disturbance
CN1172717C (en) Method for treating AIDS and its preparing method
RU2006119658A (en) MEDICINAL PRODUCT FOR Oral OBESITY AND METHOD FOR OBTAINING MEDICINAL FOR Oral Obesity Therapy
RU98105454A (en) METHOD FOR CORRECTION OF DISTURBED IMMUNE HOMEOSTASIS AND MEDICINE
RU94046321A (en) Monoclonal murine antiidiotypical antibodies, method of their preparing and their use, methods of immunization and pharmaceutical composition based on thereof
FR2838649B1 (en) ANTI-HIV COMPOSITION, METHOD OF MANUFACTURE AND MEDICINAL PRODUCT
RU2003133155A (en) METHOD FOR ERADICATING HELICOBACTER PYLORI INFECTIONS IN THE STOMACH
RU2021133162A (en) METHODS FOR THE TREATMENT OF PROSTATE CANCER USING ANTIBODIES TO PSMA/CD3
DE60216422T2 (en) NATURAL ANTIBODY WITH EFFECT TO HIV VIRUS